O

Obesity Research Institute

A $4.6 million settlement resolves claims that Lipozene weight loss pills were deceptively marketed.

ClosedUnited States-wideClaim status: Claim window closedPayout: Up to $60No longer claimable

About this settlement

Claims relate to deceptive advertising and marketing of Lipozene weight loss pills.

This settlement resolves allegations that the Obesity Research Institute misled consumers about the effectiveness of Lipozene weight loss pills. Eligible claimants could receive up to $60 from the $4.6 million fund.

Who qualifies

  • Consumers who purchased Lipozene weight loss pills.
  • Those who were allegedly misled by the product's marketing.

Up to $60

Claim status: Claim window closed

See active Settlements

Related settlements

Estée Lauder logo

Estée Lauder

No proof required

Up to $5,000

Claims opening soon

Silk and Great Value logo

Silk and Great Value

Proof required

Up to $300,000

96 days left

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

746 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon